Steffen, R., Jiang, Z., Gracias Garcia, M. L., Araujo, P., Stiess, M., Nacak, T., . . . DuPont, H. L. (2018). Rifamycin SV-MMX(®) for treatment of travellers’ diarrhea: Equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. J Travel Med.
Citación estilo ChicagoSteffen, Robert, Zhi-Dong Jiang, Mónica L. Gracias Garcia, Prithi Araujo, Michael Stiess, Tanju Nacak, Roland Greinwald, and Herbert L. DuPont. "Rifamycin SV-MMX(®) for Treatment of Travellers’ Diarrhea: Equally Effective As Ciprofloxacin and Not Associated With the Acquisition of Multi-drug Resistant Bacteria." J Travel Med 2018.
Cita MLASteffen, Robert, et al. "Rifamycin SV-MMX(®) for Treatment of Travellers’ Diarrhea: Equally Effective As Ciprofloxacin and Not Associated With the Acquisition of Multi-drug Resistant Bacteria." J Travel Med 2018.